baber/WOPTO huggingface dataset:
Patent JP-2001510397-A (JP)
IPC: B01J20/289
Filed: 1998-02-03
Abstract: A method for adsorption of a substance from a liquid sample on a fluidized bead or stirred suspension, in which the beads used comprise a base matrix and exhibit a structure having affinity to the substance, characterized in that the structure is covalently bound to the base matrix via an extender. Populations of beads in which the beads contain a filler incorporated in a base matrix and an extender are also described.
Patent JP-2002515838-A (JP)
Title: 管状端部を溶接するための溶接装置及び方法
IPC: B29C35/08
Filed: 1998-02-05
Abstract: (57)【要約】
互いに当接した一対の熱可塑性プラスチックの端部を接合するためのシステムは接合すべき管状端部の外面のまわりに延びる透明なスリーブと、管状端部内面のマンドレルとを利用している。赤外線加熱手段が透明スリーブを通って管状端部を溶融溶解させるための放射熱を与える。溶接プロセスの間、管状端部を透明なスリーブを通じて視覚的にモニターすることができる。
Patent JP-H11506243-A (JP)
Title: センサを用いて形成される信号の伝送のための車両内装置
IPC: G08C25/00
Filed: 1997-02-27
Abstract: (57)【要約】
本発明は、センサを用いて形成される物理量を表す信号が信号線路上で伝送される、車両内の装置に関しする。この装置は分圧器を含んでいる。この分圧器は、センサと、該センサの一方の端部にそれぞれ接続された少なくとも２つのインピーダンスからなっている。センサによって形成された信号は、センサの端子に接続されている信号線路を介して差分形成手段に供給される。差分形成手段を用いることにより有効信号が得られ、信号線路において干渉してきた障害信号が消去される。本発明は選択的に、信号線路対上でインピーダンスに印加される任意の電位差の伝送に対しても適用可能である。
Patent JP-2001511253-A (JP)
Title: ▲ｉｉ▼型コラーゲンフラグメントについてのアッセイ
IPC: C07K14/78
Filed: 1998-01-30
Abstract: (57)【要約】
コラーゲンフラグメントについてアッセイするための方法、キット、および試薬、ならびにそれらに基づく治療、予後、および診断方法が提供される。
Patent JP-2001515610-A (JP)
Title: リヤプロジェクションスクリーン
IPC: G02B3/08
Filed: 1998-11-30
Abstract: (57)【要約】
本発明はレンチキュラーレンズ構造体（５）と、フレネルレンズ構造体（４）とを有するリヤプロジェクションスクリーン（１）に関するものである。このフレネルレンズ構造体（４）は、立上りエッジ（９）とフレネルレンズフェーセット（７）とを有する。フレネルレンズフェーセット（７）は２部分に分割されている。第１部分（１１）は、リヤプロジェクションスクリーンの平面と角度ψを成している。第２部分（１３）はリヤプロジェクションスクリーンの平面に対しほぼ平行である。フレネルレンズ構造体（４）とレンチキュラーレンズ構造体（５）とはフレネルレンズ構造体の第２部分で互いに固着されている。
Patent JP-2001514787-A (JP)
Title: 例えば進行波管を制御するための装置
IPC: H01J23/34
Filed: 1998-01-09
Abstract: (57)【要約】
電流供給装置（１）と増幅器（２）とは、機械的／熱伝導性のインタフェース（３）を介して１つの構成ユニットに接合されている。電流供給装置（１）と増幅器チャンバ（２）との間の電気的接続は、この共通の構造ユニット内で案内されている。外部の制御信号ないし供給信号のために、共通の電気的なインタフェース（４）が設けられている。この構造は、例えば進行波管の制御に好適であり、電磁両立性が問題にならない。
Patent JP-2002515033-A (JP)
IPC: A61P39/06
Filed: 1997-05-02
Abstract: The present invention relates to compositions and methods for inhibiting and reversing nonenzymatic cross-linking (protein ageing). Accordingly, compositions are disclosed which comprise substituted imidazolium compounds capable of inhibiting the formation of, as well as reversing already formed, advanced glycosylation end products of target proteins. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein ageing can be treated.
Patent JP-2002506481-A (JP)
Title: フッ素含有ポリマー及びエレクトロルミネッセンスデバイス
IPC: C08G61/00
Filed: 1999-04-09
Abstract: (57)【要約】
式(I)の基を10〜90重量％及び式(II)、（III）、及び(IV)の基並びにこれらの混合物を10〜90重量％含むコポリマー（式中、Ｒ 1 は独立に、Ｈ、Ｃ 1 -Ｃ 20 ヒドロカルビルもしくはＳ、Ｎ、Ｏ、ＰもしくはＳｉ原子を１個以上含むＣ 1 -Ｃ 20 ヒドロカルビル、Ｃ 4 -Ｃ 16 ヒドロカルビルカルボニルオキシ、Ｃ 4 -Ｃ 16 アリール（トリアルキルシロキシ）であり、又は両方のＲ 1 はフルオレン環上において９−炭素と、Ｃ 5 -Ｃ 20 環式脂肪族構造又はＳ、Ｎ、もしくはＯのヘテロ原子を１個以上含むＣ 4 -Ｃ 20 環式脂肪族構造を形成し、Ｒ 2 は独立に、Ｃ 1 -Ｃ 20 ヒドロカルビル、Ｃ 1 -Ｃ 20 ヒドロカルビルオキシ、Ｃ 1 -Ｃ 20 チオエーテル、Ｃ 1 -Ｃ 20 ヒドロカルビルカルボニルオキシ又はシアノであり、Ｒ 3 は独立に、カルボキシル、Ｃ 1 -Ｃ 20 アルキル、Ｃ 1 -Ｃ 20 アルコキシ又は式−ＣＯ 2 Ｒ 4 (式中、Ｒ 4 はＣ 1 -Ｃ 20 アルキルである)の基であり、ａ及びｂは独立に０〜３の整数である）。
Patent MD-20040141-A (MD)
Inventor: COVALENCO ION
IPC: H03G3/34
Filed: 2004-06-02
Abstract: Inventia se refera la echipamentul autovehiculelor si poate fi utilizata in sistemele lor audio. Metoda consta in deblocarea canalului audio la o viteza predeterminata a autovehicolului. Dispozitivul de atenuare a sunetului in aparatele audio pentru vehicule include un microprocesor 1, conectat la el un detector al vitezei vehicului 3 si un comutator 2, care este unit cu o sursa a semnalului audio 4 si un amplificator 5, unit cu difuzorul 6.
Patent MX-157568-A (MX)
Inventor: PELLERIN NORVIN LEROY
IPC: D06F31/00
Filed: 1982-04-16
Abstract: There is disclosed a continuous batch type washing machine wherein means are provided for exchanging liquor in one or more of the successive compartments in which individual drums (1-8) are rotatable in order to avoid injury to the goods due to incompatibilities between the goods and the liquor which would result from transfer of the goods into a compartment containing the liquor and/or circulation of the liquor into a compartment for a drum containing the goods.
Patent NZ-200733-A (NZ)
Title: Hydrophobic mineral oil based filling compositions for cable splice cases
Inventor: DEBBAUT C A M-L
IPC: H01B7/28
Filed: 1982-05-25
Abstract: Hydrophobic filling compositions (3) comprise a mineral oil and a hydrophobic fumed silica, and optionally other additives such as a depolymerized butyl rubber, a microcrystalline wax or hydrophobic glass microspheres. The compositions have a very low water content, a good thermal stability to phase separation of oil and an unexpectedly improved water-excluding capability. These hydrophobic filling compositions have excellent electrical properties and are particularly useful as water-excluding filling compounds for splice cases, sealing connections between telecommunication cables.
Patent NZ-202880-A (NZ)
Title: Electroacoustic transducer construction using high precision moulding techniques
Inventor: WEST L L
IPC: H04R11/00
Filed: 1982-12-22
Abstract: A method of producing a transducer in which the fine tolerances are obtained by a two stage moulding process. Features include retention of the coil by the moulding process and accurate dimensioning of the magnet by depression of the soft iron core.
Patent NZ-224146-A (NZ)
Title: Pulmonary surfactant comprised of protein and lipid-fractions
Inventor: ROBERTSON BENGT
IPC: A61K35/42
Filed: 1988-04-06
Abstract: A pulmonary surfactant of animal origin made up of a high percentage of phospholipids ( SIMILAR  99%), by a protein fraction and characterized by the absence of carbohydrates and cholesterol. The surfactant of the invention, obtained through filtration, centrifugation and extraction and by chromatography in inverse phase, allows better therapeutic results in the treatment of infant and adul respiratory distress syndromes (IRDS and ARDS).
Patent NZ-236595-A (NZ)
Title: Tamper-resistant oral dosage forms
Inventor: PATELL MAHESH
IPC: A61K9/48
Filed: 1990-12-21
Abstract: A compressed, elongated caplet having a cylindrical body portion and an exterior wall, which caplet contains a medicinal ingredient, is contained in an elongated readily swallowable capsule. The capsule comprises two semicapsules (capsule cap and body) each having a tubular internal wall. The caplet exterior wall is bonded to the internal walls of both semicapsules. The resultant dosage form is tamper resistant. A method of forming such dosage form is also disclosed. <IMAGE>
Patent NZ-243981-A (NZ)
Title: Erosion protector with projecting legs and spacer(s): legs to be mounted in pouches of fabric filter
Inventor: ATKINSON FRANCIS STEWART
IPC: E02B3/12
Filed: 1992-08-17
Abstract: An erosion protection device is provided to control erosion in environments prone to water induced erosion. Each individual device includes a central core area (24), and six generally equally sized legs (12-22) projecting outward from the core (24) at equal spacing in each direction. Spacers (28) are provided at the interface of the legs (12-22) and core (24). Multiple devices are grouped together to form a protective nested group to form a protective cover (52). <IMAGE>
Patent NZ-248051-A (NZ)
Title: 2-(substituted amino)-n-[[4-(aminocarbonyl) pyrimidin-2-yl]alkyl]pyrimidine-4-carboxamide derivatives; medicaments and preparatory processes
Inventor: GEORGE PASCAL
IPC: C07D403/12
Filed: 1993-07-02
Abstract: Compounds corresponding to the general formula (I) <IMAGE> in which m represents the number 0 or 1, R1 represents a methyl group, in which case R2 represents a phenoxy(C1-C4)alkyl group, or else R1 and R2 together form, and with the nitrogen atom which carries them, a 4-phenoxy-1-piperidyl (4-phenoxypiperidino) group, a phenoxymethyl-1-piperidyl (phenoxymethylpiperidino) group or a 4-phenyl-1-piperazinyl group, and R3 represents a hydrogen atom or, when n is equal to 1, a hydroxyl group or a methoxy group. Application in therapeutics.
Patent NZ-252085-A (NZ)
Title: Reduction of activated leukocyte cell population in a fluid by irradiation of the fluid with light of a wavelength absorbed by a green porphyrin compound which is added to the fluid
Inventor: NORTH JANICE
IPC: A61K41/00
Filed: 1993-05-27
Abstract: Treatment with a set of porphyrin compounds using a photodynamic therapy approach is able selectively to lower elevated levels of activated leukocytes in a leukocyte population. This is particularly helpful in subjects containing such elevated levels of T-cell subsets, such as HIV-infected subjects.
Patent NZ-271092-A (NZ)
Title: Nucleoside-5-triphosphates and phosphoramidites with a fluorescent residue for labelling, detecting and sequencing nucleic acids
Inventor: MUEHLEGGER KLAUS
IPC: C07H21/00
Filed: 1994-07-30
Abstract: Nucleoside-5'-triphosphates and phosphoramidites which carry a residue absorbing in the long wavelength region, preferably a carbocyanine group of the general formula (I), on the base portion or on the phosphorus atomin which R1 and R2 each denote hydrogen or together form a phenyl residue; R3 denotes hydrogen if linkage with the nucleotide is via the R4 position or it denotes a -NHCS- group if linkage with the nucleotide is via the R3 position; both R4 and R5, or R5, alone denote an alkylsulfonyl group with n being a number from 3 to 5 or R4 represents a -NHCS- group with n being a number from 3 to 8, as well as the use of the compounds to label, detect and sequence nucleic acids.
Patent NZ-278069-A (NZ)
Title: Polyester polycondensation catalysts
Inventor: MARTL MICHAEL
IPC: C01G25/00
Filed: 1995-01-02
Abstract: PCT No. PCT/EP94/04333 Sec. 371 Date Jul. 5, 1996 Sec. 102(e) Date Jul. 5, 1996 PCT Filed Jan. 2, 1995 PCT Pub. No. WO95/18839 PCT Pub. Date Jul. 13, 1995For the preparation of polyesters and copolyesters, titanium dioxide/silicon dioxide coprecipitates having a composition of TiO2:SiO2=90:10 to 20:80 mol/mol and/or titanium dioxide/zirconium dioxide coprecipitates having a composition of TiO2 : ZrO2=95:5 to 70:30 mol/mol are proposed as polycondensation catalysts. They have a higher catalytic activity than Sb2O3, so that the preferred amount used is only 10 to 100 ppm, based on the esters or oligoesters to be subjected to polycondensation.
Patent NZ-284491-A (NZ)
Title: Preparation of 7-hydroxy taxane derivatives
Inventor: BASTART JEAN-PIERRE
IPC: C07D305/14
Filed: 1995-04-03
Abstract: PCT No. PCT/FR95/00420 Sec. 371 Date Oct. 3, 1996 Sec. 102(e) Date Oct. 3, 1996 PCT Filed Apr. 3, 1995 PCT Pub. No. WO95/26961 PCT Pub. Date Oct. 12, 1995This invention relates to a process for the preparation of 7-hydroxy taxanes of general formula (I) from 7-trialkylsilyl taxanes of general formula (II), wherein R1 is hydrogen, alkoxy, acyloxy, or alkoxyacetoxy, and Z is a hydrogen atom or a radical of general formula (III), wherein R2 is an optionally substituted benzyl radical or an R'2-O-CO- radical wherein R'2 is an alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, bicycloalkyl, optionally substituted phenyl or heterocyclyl radical, R3 is an aromatic alkyl, alkenyl, alkynyl, cycloalyl, phenyl, naphthyl or heterocyclyl radical and either R4 is a hydrogen atom and R5 is a hydroxyl function protecting group, or R4 and R5 together form a saturated 5- or 6-membered heterocylic ring. In general formula (II), each R, which are the same or different, is an alkyl radical optionally substituted by a phenyl radical.    <IMAGE>  (I)   <IMAGE>  (II)   <IMAGE>  (III)
Patent NZ-314888-A (NZ)
Title: Cytoplasmic male sterile brassica oleracea plant and production thereof
Inventor: BARTEN PIETER
IPC: C12N15/87
Filed: 1997-05-23
Abstract: B. oleracea plant, whose cytoplasm is provided, via protoplast fusion, with mitochondria comprising DNA at least partially originating from a B. napus plant, and which is coupled to (the property of) cytoplasmic male sterility (CMS) (i.e. responsible for cytoplasmic male sterility in the B. oleracea plant), and whose cells are provided with species-specific nuclear genome being normal for this plant.
Patent NZ-319365-A (NZ)
Title: Allogeneic mononuclear phagocytes introduced near injured site are used to promote axonal regeneration in the cns
Inventor: EISENBACH-SCHWARTZ MICHAL
IPC: A01N63/00
Filed: 1996-09-12
Abstract: Methods and compositions for the use of allogeneic mononuclear phagocytes to promote axonal regeneration in the central nervous system of a mammal are disclosed. In one embodiment, allogeneic mononuclear phagocytes are cultured together with stimulatory tissue, such as dermis or at least one nerve segment, and are subsequently administered into the central nervous system of a mammal at or near a site of injury or disease. In an alternative embodiment, autologous monocytes, preferably stimulated autologous monocytes, are administered into the central nervous system of a mammal at or near a site of injury or disease. Methods for identifying stimulatory tissue and cells and methods and compositions for cryopreserved allogeneic mononuclear phagocytes are also disclosed.
Patent NZ-319577-A (NZ)
Title: Harmful fungi control with an active substance inhibiting respiration by inhibiting the cytochrome complex III, combined with an amide
Inventor: BAYER HERBERT
IPC: A01N61/00
Filed: 1996-09-23
Abstract: he application relates to agents intended for use against harmful fungi and containing as active substances at least one compound which inhibits respiration by inhibiting the cytochrome complex III, and at least one amide compound of formula (II): A-CO-NR1R2 in which A, R1 and R2 have the meanings indicated in the description. The proposed agents are especially suitable for use against Botrytis.
Patent NZ-322632-A (NZ)
Title: A pair of co-operating refining elements intended for a disk refiner
Inventor: KJELLQVIST OLOF
IPC: D21B1/14
Filed: 1996-10-09
Abstract: PCT No. PCT/SE96/01274 Sec. 371 Date Apr. 22, 1998 Sec. 102(e) Date Apr. 22, 1998 PCT Filed Oct. 9, 1996 PCT Pub. No. WO97/18037 PCT Pub. Date May 22, 1997Apparatus for refining lignocellulose material is disclosed including two relatively rotatable refining disks separated by a refining gap which includes an inner radial portion and an outer angular portion, with the refiner elements mounted on the outer angular portions of the refiner disks including at least one wing projecting from the rotatable refining disk adjacent to the inner radial refining gap and with the stationary refining disk including a concave surface at the inlet portion so that the lignocellulose material being processed is thrown against the concave surface during its transition from the inner radial refining gap to the outer angular refining gap.
Patent NZ-325060-A (NZ)
Title: Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
Inventor: GOULET MARK
IPC: C07D403/06
Filed: 1996-12-10
Abstract: There are disclosed compounds of formula (I) and pharmaceutically acceptable salts thereof, which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related and other conditions in both men and women.
Patent NZ-333153-A (NZ)
Title: Liquid crystal compositions
Inventor: MASSAUX JEAN
IPC: C11D1/22
Filed: 1997-06-11
Abstract: The specification describes a liquid crystal composition comprising: (a) 1% to 20% of at least one non-ionic surfactant containing ethylene oxide groups; (b) 1% to 30% of a magnesium salt of a C8-C16-alkyl benzene sulphonate surfactant; (c) 0.1% to 10% of an abrasive which can be calcite, polyethylene powder or amorphous silica; (d) 1% to 20% of a water soluble glycol ether cosurfactant; (e) 0.02% to 6% of a water insoluble organic compound selected from the group consisting of perfumes, essential oils and water insoluble hydrocarbons having from 8-18 Carbons (f) 0.1% to 3% of an unsaturated fatty acid having 12-20 Carbons and (g) 20% to 97% water. The pH of the composition is from 4.5-5.0.
Patent NZ-333724-A (NZ)
Title: Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions
Inventor: KLESGES ROBERT C
IPC: A23L33/15
Filed: 1997-07-03
Abstract: A method of enhancing lean tissue mass in a subject by administering calcium to the subject. A method of enhancing bone mineral content in a physically active subject comprising administering calcium to the subject.
Patent NZ-334821-A (NZ)
Title: Method for producing epothilones
Inventor: SCHINZER DIETER
IPC: C07D319/06
Filed: 1997-01-15
Abstract: A method for producing epothilone A or B of general formula 1 wherein, R is hydrogen (A) or a methyl group (B), wherein a thiazolealkyldiene-alcohol derivative of formula 4 is esterified with a carboxylic acid of general formula 9a wherein, B is benzyl, tetrahydropyranyl and/or a silyl protecting group and R is hydrogen or methyl, the resulting ester has the ring closed by means of an olefin metathesis in the presence of a noble metal catalyst, if appropriate the hydroxyl-protecting groups are cleaved, the newly formed double bond is epoxidised and if appropriate the hydroxyl-protecting groups are cleaved.
Patent NZ-501603-A (NZ)
Title: Iodine and bromine as contrast agents for projection mammography
Inventor: SPECK ULRICH
IPC: A61K49/04
Filed: 1998-06-19
Abstract: The use of intravenous contrast agents for projection mammography. The additional intravenous administration of contrast agent, projection mammography attains a sensitivity comparable to other such diagnostic techniques, such as magnetic resonance tomography (MRT) while having a wider range of applications and avoiding the cost of MRT.  The method can be carried out without special inconvenience for the patients and  a) considerably increases sensitivity for demonstrating focal lesions in the mammae; and  b) provides additional information on the character of previously detected lesions.
Patent NZ-502785-A (NZ)
Title: Use of NR1A/2B site-selective NMDA receptor antagonist compounds for treating disease-related or drug-induced dyskinesias
Inventor: MELTZER LEONARD THEODORE
IPC: A61K31/445
Filed: 1998-09-16
Abstract: Dyskinesias in humans are treated by  administering  a therapeutically effective dose of an NR1A/2B  site-selective NMDA  receptor  antagonist compound  to  a  human  suffering therefrom.   Ar1  and  Ar2  are  independently  aryl  or   a heteroaryl  group,  either  of which  may  be  independently substituted  by  one  to three of hydroxy,  alkyl,  halogen, nitro,  cyano, carboxaldehyde, aldehyde oxime, lower  alkoxy carbonylmethyl,   acetamido,   aryl,   aralkyl,   amino,   a halogenated  alkyl group, a lower alkyl  amino  group  or  a lower  alkoxy  group; X is (CHR3)m-, where  in  each  R3  is independently  hydrogen, hydroxy  or  a  lower  alkyl  group having  1  to 6 carbon atoms; and m is 0 or 1;  each  r2  is independently  hydrogen, hydroxy  or  a  lower  alkyl  group having  1 to 6 carbon atoms; n is 1 or 2; Y is CºC,  O,  SOp wherein  p  is  0, 1 or 2, NR4 wherein R4 is hydrogen  or  a lower  alkyl  group having 1 to 6 carbon atoms or  a  single bond.   R5  is  hydrogen or hydroxyl; and  provided  Ar2  is substituted  by  at least one of hydroxyl,  alkyl,  halogen, nitro,  cyano, carboxaldehyde, aldehyde oxime, lower  alkoxy carbonylmethyl,  hydroxyl lower alkyl,  aminocarbonylmethyl, hydrazinocarbonylmethyl, acetamido, aryl, aralkyl, amino,  a halogenated  alkyl group, a lower alkyl  amino  group  or  a lower alkoxy group.
Patent NZ-511680-A (NZ)
Title: Method for preparing nucleic acid or DNA samples and a DNA extraction process using thermophilic proteases
Inventor: DANIEL ROY MCIVER
IPC: C12Q1/37
Filed: 2001-05-14
Abstract: A method for the preparation for nucleic acid samples in a closed system comprises the steps of: i) adding at least thermophilic proteinase to a sample containing nucleic acid for testing and ii) incubating the sample for a preferred period at 65080oC as required to effect one or more of lysis of cells, digestion of proteins, digestion of cell-wall enzymes, via activity of the thermophilic proteinase, the method further comprises the step of incubating the sample at or above 90oC to effect autolysis and/or denaturation of the thermophilic proteinase wherein the incubation takes place in a closed system without the addition of further denaturing agents. Preferably the thermophilic proteinase is derived from Bacillus sp. str. Ak1 or EA1. Also described are methods of identifying thermophilic proteinases.
Patent NZ-513250-A (NZ)
Title: Comminuting apparatus with rotor rotatable about first axis which carries disc rotatable about second axis
Inventor: COOK PHILLIP MALCOLM
IPC: B02C18/24
Filed: 2001-07-30
Abstract: Rotor 1 is rotatable about a first axis and in turn causes (via drive 6) disc 4 to rotate about a second axis while also rotating about the first axis. Screen 10 is provided for comminuted material to pass through.
Patent NZ-513940-A (NZ)
Title: Canopy
IPC: E04C3/04
Filed: 2001-09-04
Abstract: A connection assembly for attaching overhead beams to pots for use in building structures, comprising: a post, a first beam member, primary connection means capable of being disposed in a released state to allow the first beam to be slidably movable relative to the post and an engaged state where the first beam member is fixedly attached to the post, a second beam member, and a secondary connection means capable of being disposed in a released state to allow the second beam member to be slidably movable relative to the first beam member and an engaged state where the second beam member is fixedly attached to the first beam member.
Patent NZ-514515-A (NZ)
Title: Organ arrest, protection and preservation using a potassium channel operator and/or adenosine receptor and a local anaesthetic
Inventor: DOBSON GEOFFREY PHILLIP
IPC: A61K31/4409
Filed: 2000-03-22
Abstract: The use of a composition for arresting, protecting and or preserving an organ. The organ may include a heart, and may be an organ originating from the circulation, respiratory, urinary, digestive, reproductive and neurological systems. The composition includes: a) either or both a potassium channel opener or agonist, and an adenosine receptor agonist, and b) a local anaesthetic. The potassium channel opener or agonist may include the following: Nicorandil, diaoxide, minoxidil, filodipine, verapamil, pimiozide, and nimodipine. The adenosine receptor agonist may include: N6-cyclopentyladenosine, N-ethylcarboxamido adenosine and 2- chloroadenosine. The local anaethetic may include the following: Mexiletine, class 1B antiarrhythmic agent such as lignocaine, prilocaine, and mipivacaine.
Patent NZ-514615-A (NZ)
Title: Database adapted to receive information via text messages(SMS) or WAP from users
Inventor: SMITH BRYAN LESLIE
IPC: G06F17/40
Filed: 2001-10-04
Abstract: A system for collecting and storing information includes: a database storage means which is adapted to store information received via S.M.S or W.A.P networks, storing information in any easily searchable and retrievable format, and date and time stamping each message for later retrieval, wherein the access to and ability to conduct searches is restricted to a specified " "law enforcement agency".
Patent NZ-516485-A (NZ)
Title: Wall frame assembly table with supports for peripheral edge spaced apart to allow debris to fall between supports
Inventor: OLDEN MARC
IPC: B25B11/02
Filed: 2000-10-06
Abstract: The table consists of a work top supported by the frame and adapted to support wall frame elements. The work top has a peripheral edge and wall frame element supports extending outwardly. The supports are sized to support wall frame elements, and are spaced apart so that debris in the region of the work top peripheral edge can fall between the supports and is inhibited from accumulating on the supports.